Skip to main content
Premium Trial:

Request an Annual Quote

There It Goes

The 2007 Journal of Clinical Oncology paper from Duke University's Anil Potti and his colleagues on pharmacogenomic strategies to treat people with advanced non–small-cell lung cancer has been retracted, reports Ivan Oransky at Retraction Watch. In the retraction, the article authors write that they "wish to retract this article because they have been unable to reproduce the experiments." Oransky notes that it is the journal's policy to have each author agree to the retraction and its wording and reports that Potti agreed to the retraction. Potti has also falsely said that he is a Rhodes Scholar and Oransky says that Potti "may have also faked an analysis of how breast cancer responds to chemotherapy."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.